Assembling intelligence…
CENTER FOR DRUG EVALUATION AND RESEARCH (CDER): BENEFIT, RISK, AND QUALITY ASSESSMENT
| Company | Orders | Obligated | Latest order end |
|---|---|---|---|
| CAITTA INC. | 10 | $2.9M | 2027-07-24 |
| 75F40123F19011 CAITTA INC. · Food and Drug Administration | $1.2M | 2027-07-24 |
| 75F40122F19009 CAITTA INC. · Food and Drug Administration | $324K | 2025-02-19 |
| 75F40120F19006 CAITTA INC. · Food and Drug Administration | $313K | 2022-02-19 |
| 75F40123F19010 CAITTA INC. · Food and Drug Administration | $264K | 2025-05-03 |
| 75F40119F19002 CAITTA INC. · Food and Drug Administration | $240K | 2020-09-23 |